Multi-Institutional IMPACT Validation

NCT06850857 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2025-06-18

No results posted yet for this study

Summary

The goal of this observational study is to validate a novel patient-reported outcome measure (PROM) for patients suffering maxillofacial trauma: The Integrated Modular Patient-Reported Outcome Assessment for Craniomaxillofacial Trauma (IMPACT). The primary question is:

Are the IMPACT modules valid and reliable measures to study quality-of-life (QOL) in patients with maxillofacial trauma?

Patients presenting for routine clinic follow-up for maxillofacial trauma will be invited to complete the IMPACT in addition to the 15 Dimension (15D) QOL survey as a control.

Conditions

  • Facial Injuries
  • Mandible Fracture
  • Le Fort
  • Zygomaticomaxillary Complex Fracture
  • Nasal Fracture
  • Orbital Fractures
  • Zygoma Fracture
  • Orbital Floor Fracture
  • Facial Laceration

Interventions

OTHER

IMPACT-G Module

Administration of the general IMPACT survey module.

OTHER

IMPACT-N Module

Administration of the IMPACT-N survey module.

OTHER

IMPACT-O Module

Administration of the IMPACT-O survey module.

OTHER

IMPACT-J Module

Administration of the IMPACT-J survey module.

OTHER

15D Control Survey

Administration of the 15D QOL control survey.

Sponsors & Collaborators

  • University of California, San Francisco

    collaborator OTHER
  • University of California, Davis

    collaborator OTHER
  • University of Maryland

    collaborator OTHER
  • Vanderbilt University

    collaborator OTHER
  • University of Tennessee

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-07-01
Primary Completion
2026-06-30
Completion
2026-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06850857 on ClinicalTrials.gov